Palvella Therapeutics, Inc.

Historical 13F Holders

Symbol
PVLA
CUSIP
697947109
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 697947109 since 12/18/2024, largest first.

Filer % of Class Filed
Kaupinen Wes 13D
14.6% 12/20/2024
Event 12/13/2024
Jennison Associates LLC 13G/A 7.7% 10/28/2026
Event 9/30/2026
Suvretta Capital Management, LLC 13G/A
7.4% 11/13/2025
Event 9/30/2025
Prudential Financial Inc 13G 6.7% 8/10/2026
Event 6/30/2026
Frazier Life Sciences Public Fund, L.P. 13G/A
5.9% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G 5.7% 7/29/2026
Event 6/30/2026
First Light Asset Management, LLC 13G/A
5.3% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Biotechnology Value Fund L P 13G/A
4.7% 8/14/2026
Event 6/30/2026
Samsara BioCapital, L.P. 13G/A
3.1% 8/14/2025
Event 6/30/2025
Dellora Investments LP 13G/A
1.3% 12/17/2024
Event 12/13/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 202 14.6 M $2.01B
2026 Q2 198 14.1 M $2.15B
2026 Q1 182 13.3 M $1.65B
2025 Q4 145 9.76 M $1.02B
2025 Q3 100 8.53 M $534M
2025 Q2 66 5.91 M $133M
2025 Q1 42 5.12 M $143M
2024 Q4 34 4.03 M $48.4M